Status: Baseline only
Increase the proportion of adults with diagnosed diabetes who receive an annual urinary albumin test
Baseline: 48.7 percent of Medicare beneficiaries with diabetes mellitus had urinary albumin testing in 2016
Target: 66.6 percent
Data Source: United States Renal Data System (USRDS), NIH/NIDDK
The goal of screening for high levels of albumin in the urine is to help prevent end-stage kidney disease (ESKD) in people with diabetes. Finding high levels of this protein in urine is an effective way to identify early kidney damage caused by diabetes. This can lead to interventions to slow kidney damage or stop it from getting worse.
Workgroup: Diabetes Workgroup